<DOC>
	<DOCNO>NCT02326194</DOCNO>
	<brief_summary>Since first outbreak occur 1976 , Zaire Ebola virus associate 14 outbreak report 2014 . The Zaire Ebola virus 2014 cause serious outbreak consider new epidemic strain , GP homology gene 97.6 % , compare GP gene strain 1976 . This investigational Ad5-EBOV vaccine develop accord 2014 epidemic Zaire strain formulate freeze-dry product could store 4℃ . This single center , double-blind , placebo control , dose-escalation phase 1 clinical trial . This study determine safety side-effect profile , immunogenicity investigational Ad5-EBOV vaccine .</brief_summary>
	<brief_title>A Phase I Clinical Trial Evaluate Ebola Adenovirus Vector Vaccine ( Ad5-EBOV ) Healthy Adults .</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hemorrhagic Fever , Ebola</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 18 60 year . Able understand content inform consent willing sign inform consent Able willing complete seclude study process whole study followup period ( 6 month ) . A body mass index ( BMI ) &lt; 35 Hemoglobin 110150g/L female , 120160g/L male . White blood cell ( WBC ) 4.010.0×109 cells/L Total lymphocyte Count 0.84.5×109 cells/L Platelets 100300×109 cells/L Alanine aminotransferase ( ALT ) 040U/L Serum creatinine 44106μmol/L Partial thromboplastin time ( PTT ) 2040 second Prothrombin time ( PT ) 1014 second Negative HIV diagnostic blood test Axillary temperature ≤37.0°C day enrollment General good health establish medical history physical examination . Family history seizure , epilepsy , brain mental disease Subject medical history following : allergic history vaccination drug , allergic ingredient Ad5EBOV vaccine , mannitol Woman pregnant , breastfeed positive βHCG ( human chorionic gonadotropin ) pregnancy test ( urine ) day enrollment , become pregnant next 6 month Any acute fever disease infection last 7 day Major congenital defect wellcontrolled chronic illness , asthma , diabetes , thyroid disease Hereditary angioneurotic edema acquire angioneurotic edema Urticaria last one year Asplenia functional asplenia Platelet disorder bleed disorder may cause injection contraindication Faint sight blood needle . Prior administration immunodepressant corticosteroid , antianaphylaxis treatment , cytotoxic treatment last 6 month Prior administration blood product last 4 month Prior administration research medicine last 1 month Prior administration attenuate vaccine last 1 month Prior administration inactivate vaccine last 14 day Current antituberculosis prophylaxis therapy Any condition opinion investigator may interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Safety , immunogenicity , Ebola</keyword>
</DOC>